91 |
Impact of economically targeted conservation delivery on agricultural revenue across a range of commodity pricesBedwell, Emily Kranz 06 August 2021 (has links) (PDF)
The collective body of U.S. legislation, colloquially known as the Farm Bill, authorizes a suite of practices and programs under its Conservation Title. This includes the Conservation Reserve Program (CRP), which incentivizes agricultural producers to remove arable land from production to enhance soil retention, improve water quality, and restore wildlife habitat. Conservation Practice 33: Habitat Buffers for Upland Birds (CP-33) was the first CRP practice to target wildlife habitat restoration. CP-33 incentivizes producers to reestablish native herbaceous vegetation along crop field margins. Producers are often concerned with the economic opportunity costs of CP-33 enrollment. I used yield data derived from 44 agricultural fields in the Mississippi Alluvial Valley, USA to compare the environmental and economic opportunities associated with CP-33 establishment. I used yield data to develop a revenue distribution function to illustrate CP-33 revenue as commodity prices fluctuate. I found that as commodity prices increase, CP-33 implementation becomes less profitable.
|
92 |
A large-scale targeted proteomics of plasma extracellular vesicles shows utility for prognosis prediction subtyping in colorectal cancer / 血漿細胞外小胞体を対象とした大規模ターゲットプロテオミクスの大腸癌予後予測サブタイプ分類における有用性Kasahara, Keiko 23 May 2023 (has links)
京都大学 / 新制・論文博士 / 博士(医学) / 乙第13561号 / 論医博第2290号 / 新制||医||1067(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 武藤 学, 教授 今中 雄一, 教授 村川 泰裕 / 学位規則第4条第2項該当 / Doctor of Medical Science / Kyoto University / DFAM
|
93 |
EGFR-Targeted Polymeric Micelles For Targeted Pc 4-PDT Of Oropharyngeal TumorsMaster, Alyssa M. 23 August 2013 (has links)
No description available.
|
94 |
Precise genomic deletions and insertions via paired prime editing for crop bioengineeringMoreno-Ramírez, Jose Luis 08 1900 (has links)
CRISPR/Cas has been developed for targeted mutagenesis in diverse species, including plants. However, precise genome editing via homology-directed repair (HDR) is inefficient in plants, limiting our ability to make large deletions or insertions in the plant genomes. Prime editing increases the control over the desired editing and allows the precise introduction of all types of mutations, including insertion, deletions, and all possible base conversions, albeit at low efficiencies. Here, we designed a dual prime editing system to generate large deletions and precise insertions of sequences by repairing template complementarity. We coupled dual pegRNA with Cas9 nickase (nCas9) to generate deletions and insertions. In another modality, we used dual pegRNA with wild-type Cas9 to generate double-stranded breaks to improve the editing at the targeted sites. We tested dual pegRNAs to delete the last exon in OsCCD7, delete the microRNA targeted sequence in OsIPA, and insert the T7 promoter in the 3'UTR of OsALS. Our results showed a high frequency of targeted insertion of the T7 promoter sequence in the 3'UTR of OsALS with wtCas9 and nCas9. Sanger sequencing analysis showed partial deletions at the targeted locus. Further improvements in the designs of pegRNAs will increase the precise genome insertions and deletions in plants.
|
95 |
Inhibitoren des NF-kappaB pathways zur in vitro Blockade der Inflammation und proapoptotischen Sensitivierung des oralen Plattenepithelkarzinoms für den prospektiven Einsatz in der Tumortherapie / Inhibitors of the NF-kappaB pathway for in vitro blockade of inflammation and proapoptotic sensitization of oral squamous cell carcinoma for prospective use in tumor therapyScheurer, Mario Joachim Johannes (Dr. med. dent.) January 2022 (has links) (PDF)
Entzündliche Prozesse stellen einen zentralen Aspekt der Karzinogenese dar und können sowohl zur Induktion als auch zum Progress von Tumoren beitragen. Der NF-kB-Signalweg ist einer der wichtigsten Signaltransduktionswege der In- flammation und Tumorpromotion, was ihn zur plausiblen Zielstruktur für die pros- pektive klinische Tumortherapie machen könnte. In der vorliegenden Arbeit wur- den die Eigenschaften von vier unterschiedlich targetierenden NF-kB-pathway- Inhibitoren – Cortisol, MLN4924, QNZ und TPCA1 – auf die Inflammation, Zell- proliferation und proapoptotische Sensitivierung am in vitro Modell des HNSCC untersucht. Es konnte gezeigt werden, dass die spezifische Auswahl des Inhi- bitors bzw. seines targets entscheidend für den wirkungsvollen Einsatz dieser Wirkstoffgruppe in der antiproliferativen Therapie des HNSCC zu sein scheint. Beispielsweise vermittelte MLN4924 die Freisetzung von IL-8. Cortisol bewirkte die Resistenz der FasL-induzierten Apoptose von HNSCC-Zellen. QNZ wirkte in einigen Zelllinien antiproliferativ und sensitivierend für den FasL-induzierten Zell- tod, beeinflusste jedoch in diesem Zusammenhang kontraproduktiv die IL-8-Sek- retion. Dies disqualifizierte diese Wirkstoffe für die Anwendung in der Therapie von Kopf-Hals-Tumoren. Dahingegen qualifizierte sich TPCA-1 aufgrund folgen- der Eigenschaften als geeigneter Wirkstoff für den prospektiven klinischen Ein- satz:
1) TPCA-1 wirkte antiproliferativ,
2) hemmte die TNF-a-induzierte Inflammation,
3) regulierte die IL-8-Expression herab,
4) wirkte sensitivierend für den TNF-a-induzierten Zelltod,
5) interferierte kaum mit der FasL-vermittelten Apoptose und 6) induzierte Apoptose. / Inflammatory processes represent a central aspect of carcinogenesis and may contribute to both tumour induction and progression. The NF-kB signalling pathway is one of the most important signal transduction pathways in inflammation and tumour promotion, which could make it a plausible target for prospective clinical tumour therapy. In the present study, the properties of four different targeting NF-kB pathway inhibitors - cortisol, MLN4924, QNZ and TPCA1 - on inflammation, cell proliferation and proapoptotic sensitivity were investigated in an in vitro model of HNSCC. It was shown that the specific selection of the inhi- bitor or its target seems to be crucial for the effective use of this group of drugs in the antiproliferative therapy of HNSCC. For example, MLN4924 mediated the release of IL-8, and cortisol induced the resistance of FasL-induced apoptosis of HNSCC cells. QNZ had an antiproliferative effect in some cell lines and was sensitive to FasL-induced cell death, but counteracted IL-8 secretion in this context. This disqualified these agents for use in the therapy of head and neck tumours. In contrast, TPCA-1 qualified as a suitable agent for prospective clinical use due to the following properties:
1) TPCA-1 had an antiproliferative effect,
2) inhibited TNF-a-induced inflammation,
3) down-regulated IL-8 expression,
4) was sensitive to TNF-a-induced cell death,
5) hardly interfered with FasL-mediated apoptosis, and 6) induced apoptosis.
|
96 |
ENGINEERING RGD-MODIFIED LIPOSOMES FOR TARGETED DRUG DELIVERY TO ACTIVATED PLATELETSHuang, Guofeng 18 July 2006 (has links)
No description available.
|
97 |
Targeting Nuclear Export in Chronic Lymphocytic LeukemiaHing, Zachary Andrew 18 September 2018 (has links)
No description available.
|
98 |
A comparison of safety and efficacy of cytotoxic versus molecularly targeted agents in pediatric phase I solid tumor oncology trialsDorris, Kathleen 19 April 2012 (has links)
No description available.
|
99 |
Transcription Inhibitors as Anti-Adhesion AgentsDagia, Nilesh M. 14 July 2004 (has links)
No description available.
|
100 |
Monoclonal Antibody and Liposomal Nanoparticle-based Targeting Therapies for Chronic Lymphocytic LeukemiaMao, Yicheng 18 December 2012 (has links)
No description available.
|
Page generated in 0.0446 seconds